| Followers | 144 |
| Posts | 27997 |
| Boards Moderated | 4 |
| Alias Born | 02/07/2004 |
Friday, April 17, 2020 7:24:33 AM
Bvxv - here is latest from Mar 19th
report. So the results are year end and not Q2
True. But I am referring to :
Analysis of the data is ongoing, and the clinical study report (CSR) is expected in Q2 2020.
https://www.prnewswire.com/il/news-releases/preliminary-data-from-nihniaid-sponsored-phase-2-clinical-trial-of-biondvaxs-m-001-universal-influenza-vaccine-candidate-validates-results-of-previous-clinical-trials-300999644.html
Of course “Topline results will be available before the end of 2020, but this is for Phase 3
Recent SLGL News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/24/2026 09:16:03 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/24/2026 09:14:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 03/24/2026 04:15:06 AM
- Sol-Gel Technologies Ltd. Announces Pricing of Oversubscribed Underwritten Offering • GlobeNewswire Inc. • 03/24/2026 01:38:22 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 03/19/2026 09:03:09 PM
- Sol-Gel Files Annual Report on Form 20-F for the Year Ended December 31, 2025 • GlobeNewswire Inc. • 03/19/2026 12:53:28 PM
- Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] • Edgar (US Regulatory) • 03/19/2026 12:51:43 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 07:12:53 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 04:26:07 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 04:24:12 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 04:20:46 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 04:18:21 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 04:15:32 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/12/2026 11:11:02 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/26/2026 11:21:09 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/24/2026 12:41:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/15/2026 11:54:30 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/17/2025 01:47:45 PM
- Sol-Gel Provides Update Following Unblinding of Phase 1b Study of SGT-210 in Darier Disease • GlobeNewswire Inc. • 12/17/2025 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/20/2025 01:44:10 PM
- Sol-Gel Reports Third Quarter 2025 Financial Results and Provides Corporate Updates • GlobeNewswire Inc. • 11/20/2025 12:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/14/2025 11:00:31 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/25/2025 06:12:52 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/04/2025 11:00:10 AM
- Sol-Gel Announces Health Canada Approval of EPSOLAY® • GlobeNewswire Inc. • 09/04/2025 11:00:00 AM
